Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Entourage Health Corp V.ENTG

Alternate Symbol(s):  ETRGF

Entourage Health Corp. is a Canada-based license holder producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a 26,000 square feet indoor facility in Aylmer, Ontario (the Aylmer Facility), specializing in product development and fulfillment for both adult-use and medical cannabis. The Company is focused on building a portfolio of brands in the Canadian market, including its brand Color Cannabis, mainstream brand Saturday Cannabis, medical cannabis product brand Starseed Medicinal and its craft cannabis brand Syndicate Cannabis. The Company produces a diverse portfolio of cannabis and cannabis derivative products, including oils, capsules, soft chews, topicals, beverages and vapes, for sale in both the medical and adult-use markets across Canada. Its elite adult-use product portfolio also includes Dime Bag a pre-roll offering, sold across eight provincial distribution agencies.


TSXV:ENTG - Post by User

Post by HappyFlowers25on May 21, 2021 9:55am
268 Views
Post# 33247188

WeedMD- Q1 2021 finanbcial - record milestones achieved

WeedMD- Q1 2021 finanbcial - record milestones achievedTORONTO, May 21, May 21, 2021 (GLOBE NEWSWIRE via COMTEX News Network) -- Company financials to be filed after market on May 28, 2021 and operational outlook to be provided during call, including first quarter 2021 record milestones achieved WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) ("WeedMD" or the "Company"), a federally licensed producer and distributor of medical-grade cannabis, announced today that it will file its financial statements and management's discussion and analysis for the fourth quarter and fiscal year ended December 31, 2020, after market close on Friday May 28, 2021. The Company will host a conference call to discuss these results, and provide an operational update as well as recap of achievements from the the first quarter of 2021 on Monday, May 31, 2021 at 10 a.m. Eastern Time. The call will be hosted by CEO and Executive Chairman George Scorsis and newly appointed CFO Beth Carreon. Management will be available for questions following opening remarks. Conference Call Details: Date: Monday, May 31, 2021 Time: 10 a.m. Eastern Time Dial-in Number: Canada/USA: 1-800-319-4610. International Toll: 1-604-638-5340 Participants, please dial in and ask to join the WeedMD call Replay Dial-in: Canada/USA: 1-800-319-6413. International Toll: 1-604-638-9010 Replay Access Code: 6629 Available after 12:00 p.m. Eastern Time, until June 30, 2021 Updated investor presentation and corporate deck can be found here. Access WeedMD's 2021 Shareholder Newsletter here and information about upcoming corporate events here
<< Previous
Bullboard Posts
Next >>